Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements

Overview of attention for article published in ClinicoEconomics and Outcomes Research: CEOR, May 2020

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (62nd percentile)
High Attention Score compared to outputs of the same age and source (88th percentile)

Mentioned by

twitter: 4 X users

Citations

dimensions_citation: 8 Dimensions

Readers on

mendeley: 20 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 5 X posts from 4 X users, with an upper bound of 5,199 followers.

https://t.co/Bppsk8cqdr.

10 May 2020

Reply Repost Favourite

Nice paper! @phillips_jacks and @challam19

06 May 2020

Reply Repost Favourite

An interesting piece on depot buprenorphine (eg Buvidal). The challenge is understanding whether these modelled financial impacts can translate into real world savings & who is likely to benefit most from the introduction of this technology/interventio

06 May 2020

Reply Repost Favourite

@clairerobbinsok

06 May 2020

Reply Repost Favourite

Budget Impact Analysis of the Introduction of Injectable Prolonged-Rel | CEOR https://t.co/m9WXWyKjXD

06 May 2020

Reply Repost Favourite

Dove Medical Press

Article Metrics

Budget Impact Analysis of the Introduction of Injectable Prolonged-Release Buprenorphine on Opioid Use Disorder Care Resource Requirements

About this Attention Score

Mentioned by

Citations

Readers on